Drug Research
Batavia and KU Leuven join forces to accelerate development of highly promising COVID-19 vaccine candidate
KU Leuven, a leading research institution and one of the top 50 universities in the world and Batavia Biosciences, a contract development and manufacturing organization focused on delivering sustainable manufacturing solutions in the field of vaccines and oncology, announce...
News
Ufovax extends IP portfolio to include patent covering the design of an optimized antigen for COVID-19
Ufovax, a vaccine biotechnology company, has extended its intellectual property portfolio to include an exclusive global license to a patent covering the design of an optimized antigen for SARS-CoV-2 (“COVID-19”). The patent, entitled Stabilized Coronavirus Spike (S) Protein Immunogens...
News
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years
BD, a leading global medical technology company, announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six...
News
New destinations for life-saving pharmaceutical products
DoKaSch Temperature Solutions and Air Europa have signed a Master Rental Agreement about the usage of the temperature-controlled Opticooler packaging solution. The collaboration opens up important new direct routes between Europe and Latin America. Until now, several destinations could...
Drug Research
UK Approves Pfizer COVID-19 Vaccine: Expect A Next Week Roll-Out
In a historic occurrence which has taken the world by storm, the UK Government has officially approved the usage of Pfizer’s coronavirus vaccine. This move may bring a lot of intensity to other countries and their respective regulators too....
News
Kuehne+Nagel and Qatar Airways Cargo donate freight services to support global Covid-19 response
As part of the “1 million kilos” charitable initiative, Kuehne+Nagel and Qatar Airways Cargo donate air freight services to UNICEF, supporting the agency’s global efforts in the fight against the Covid-19 pandemic.
Triggered by the Covid-19 crisis, the “1 million...
News
Russia’s Sputnik V likely to be available for supply from January
Russia's Sputnik-V COVID-19 vaccine might become available for supply as early as next month, the country's sovereign wealth fund RDIF's top official told ThePrint.
According to Kirill Dmitriev, the Chief Operating Officer (COO) of RDIF, they are hoping for approval...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















